Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
NCT04698382 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-03-22
Summary
This study seeks to determine the the impact of COVID-19 on the incidence, characteristics, management and outcome of patients admitted to U.S. hospitals with non-COVID-19 related sepsis.
Conditions
- Sepsis
- Septic Shock
Sponsors & Collaborators
-
Emory University
collaborator OTHER -
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
Sameer S Kadri, MD, MS · National Institutes of Health, Clinical
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2022-12-31
- Completion
- 2023-12-31
Countries
- United States
Study Locations
More Related Trials
-
Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis
NCT04644302 ·Status: COMPLETED
-
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813 ·Status: UNKNOWN
-
VTE Incidence in Severe Sepsis and Septic Shock
NCT02353910 ·Status: COMPLETED
-
Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis
NCT06491966 ·Status: RECRUITING
-
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
NCT05383963 ·Status: RECRUITING
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
STUDY00015328: Sepsis Endotypes
NCT03146546 ·Status: ENROLLING_BY_INVITATION
-
Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.
NCT01450358 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study
NCT02188992 ·Status: COMPLETED
-
A Prospective Observational Study of Sepsis
NCT05309889 ·Status: UNKNOWN
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Coagulation Disturbances in COVID-19 Septic Patients
NCT05496816 ·Status: COMPLETED
-
Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection
NCT04600141 ·Status: COMPLETED ·Phase: PHASE3
-
Near Patient Molecular Testing in Sepsis
NCT05469048 ·Status: COMPLETED
-
Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis)
NCT01668329 ·Status: COMPLETED
-
The Early Coagulopathy for the Prognosis in Sepsis
NCT04582188 ·Status: UNKNOWN
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
Shock Indices Use for Early Mortality From Septic Shock
NCT05088109 ·Status: UNKNOWN
-
Comparing an Automated to a Conventional Sepsis Clinical Prediction Rule
NCT01505478 ·Status: WITHDRAWN
-
Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients
NCT00781040 ·Status: COMPLETED
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN
-
Endothelial Microparticles as a Biomarker for Diagnosis and Prognosis in Early Sepsis
NCT01998139 ·Status: COMPLETED
-
Sepsis and Myocarditis
NCT07079605 ·Status: RECRUITING